Birdwatch Note
2023-08-13 09:13:47 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
「世界では一人の患者に処方する薬剤は最大で4剤まで/特に60歳以上の患者には2剤までというルールがある」という記述は事実誤認です。ポリファーマシー(多剤併用)は世界的にみられる現象であり、日本でのみ多量の薬剤が処方されるという主張には根拠が提示されていません。 https://pubmed.ncbi.nlm.nih.gov/25628499/ また、日本の平均寿命は世界的にトップレベルであり、健康寿命については世界一です。 https://memorva.jp/ranking/unfpa/who_whs_healthy_life_expectancy.php
Written by 5E4EEEAEFEC4653B759CA2693ACBC3AA1FFE1CD4BAE4AA88B66211844AF3FAD4
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1690503148715286528
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1690652858885243216
- noteId - 1690652858885243216
- participantId -
- noteAuthorParticipantId - 5E4EEEAEFEC4653B759CA2693ACBC3AA1FFE1CD4BAE4AA88B66211844AF3FAD4 Participant Details
- createdAtMillis - 1691918027027
- tweetId - 1690503148715286528
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 「世界では一人の患者に処方する薬剤は最大で4剤まで/特に60歳以上の患者には2剤までというルールがある」という記述は事実誤認です。ポリファーマシー(多剤併用)は世界的にみられる現象であり、日本でのみ多量の薬剤が処方されるという主張には根拠が提示されていません。 https://pubmed.ncbi.nlm.nih.gov/25628499/ また、日本の平均寿命は世界的にトップレベルであり、健康寿命については世界一です。 https://memorva.jp/ranking/unfpa/who_whs_healthy_life_expectancy.php
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2023-08-13 09:13:47 UTC (1691918027027) |
2023-08-14 00:13:49 UTC (1691972029944) |
CURRENTLY_RATED_HELPFUL | 2023-08-14 02:09:58 UTC (1691978998272) |
NEEDS_MORE_RATINGS | 2023-08-14 00:13:49 UTC (1691972029944) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
rated at | rated by | |
2023-08-13 16:10:33 -0500 | Rating Details | |
2023-08-13 11:32:47 -0500 | Rating Details | |
2023-08-13 11:26:48 -0500 | Rating Details | |
2023-08-13 11:22:13 -0500 | Rating Details | |
2023-08-13 11:01:49 -0500 | Rating Details | |
2023-08-13 10:45:23 -0500 | Rating Details | |
2023-08-13 10:42:29 -0500 | Rating Details | |
2023-08-13 10:37:23 -0500 | Rating Details | |
2023-08-13 10:35:00 -0500 | Rating Details | |
2023-08-13 10:20:38 -0500 | Rating Details | |
2023-08-13 10:17:24 -0500 | Rating Details | |
2023-08-13 10:12:21 -0500 | Rating Details | |
2023-08-13 10:05:31 -0500 | Rating Details | |
2023-08-13 10:04:24 -0500 | Rating Details | |
2023-08-13 09:54:47 -0500 | Rating Details | |
2023-08-13 09:43:29 -0500 | Rating Details | |
2023-08-13 07:58:29 -0500 | Rating Details | |
2023-08-13 07:39:40 -0500 | Rating Details | |
2023-08-13 07:19:53 -0500 | Rating Details | |
2023-08-13 06:52:12 -0500 | Rating Details | |
2023-08-13 06:41:02 -0500 | Rating Details | |
2023-08-13 06:03:36 -0500 | Rating Details | |
2023-08-13 05:31:12 -0500 | Rating Details | |
2023-08-13 05:28:10 -0500 | Rating Details | |
2023-08-13 05:18:14 -0500 | Rating Details | |
2023-08-13 05:16:02 -0500 | Rating Details | |
2023-08-13 04:25:59 -0500 | Rating Details | |
2023-08-13 04:24:03 -0500 | Rating Details | |
2023-08-13 04:21:09 -0500 | Rating Details | |
2023-08-13 04:14:47 -0500 | Rating Details | |
2023-08-13 22:33:01 -0500 | Rating Details | |
2023-08-15 12:47:48 -0500 | Rating Details | |
2023-08-15 23:07:28 -0500 | Rating Details | |
2023-08-13 06:45:54 -0500 | Rating Details | |
2023-08-13 04:29:55 -0500 | Rating Details | |
2023-08-13 04:20:25 -0500 | Rating Details | |
2023-10-28 01:02:47 -0500 | Rating Details | |
2023-10-28 02:48:05 -0500 | Rating Details |